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Abstract Bacterial tyrosyl-tRNA synthetases occur in two
large subfamilies, TyrRS and TyrRZ, that possess about 25%
amino acid identity. Their amino-terminal region, the active site
domain, is more conserved (s 36% identity). The carboxy-
terminal segment of these enzymes includes the tRNA binding
domain and contains only few conserved residues. Replacement
of three of these residues in Acidithiobacillus ferrooxidans
TyrRZ revealed that S356 and K395 play roles in tRNA binding,
while H306, a residue at the junction of the catalytic and tRNA
binding domains, stabilizes the Tyr-AMP:TyrRZ complex. The
replacement data suggest that conserved amino acids in A.
ferrooxidans TyrRZ and Bacillus stearothermophilus TyrRS
play equivalent roles in enzyme function. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Tyrosyl-tRNA synthetase (TyrRS), a class I aminoacyl-
tRNA synthetase [1] forming tyrosyl-tRNA for protein syn-
thesis, has been well characterized [2^4]. The structure of the
class de¢ning the amino-terminal catalytic core of Bacillus
stearothermophilus TyrRS complexed with tyrosyl-adenylate
has been determined [4,5]. Crystallographic and hydrodynam-
ic data led to the proposal that the enzyme is a homodimer.
Structural and kinetic data provided a detailed description of
the enzyme’s interactions with ATP, tyrosine and analogs of
intermediates in the activation reaction [4]. The more con-
served N-terminal domain with the HIGH region includes
the catalytic core [5]; this is followed by the more idiosyn-
cratic C-terminal tRNA binding domain. Based on spectro-
scopic analysis the carboxy terminus of B. stearothermophilus
TyrRS is structured in solution. The lack of structural infor-
mation on this region of the protein by X-ray crystallography
is probably due to £exibility at the junction of the catalytic
and the tRNA binding domain [6,7]. No structural data are
yet known for the complex of the enzyme with tRNA. How-
ever, mutational analysis has led to a model of the interaction
of one molecule of tRNA with the dimer [8].
Previously we reported the sequence of Acidithiobacillus
ferrooxidans tyrosyl-tRNA synthetase (TyrRZ) predicted
from the sequence of the tyrZ gene [9]. This protein, which
is active when produced in vivo in Escherichia coli, shows 44%
identity at the amino acid level with the tyrZ gene product
from Bacillus subtilis [10]. Recent advances in genome se-
quencing con¢rmed that the two subfamilies of tyrosyl-
tRNA synthetases (TyrRS and TyrRZ) are widely represented
in the bacterial domain (see below [11,12]). Members of the
TyrRZ subfamily share no more that 25% identity with
TyrRS. Multiple sequence alignments of members of the
two subfamilies revealed that certain amino acids known to
be involved in either the binding of substrates or the catalysis
are conserved [9]. The majority of these residues are clustered
at the N-terminal domain. However, a few amino acids in the
putative tRNA binding domain are also conserved. In this
work we attempted to de¢ne the role of some of those con-
served amino acids in TyrZ.
2. Materials and methods
2.1. DNA manipulations
All DNA manipulations were carried out as described [13].
2.2. Cloning of tyrZ
The A. ferrooxidans gene was obtained from the plasmid pTR1 [14]
and cloned in pGEX-2T (Pharmacia) generating recombinant plasmid
pGT9. The cloning procedure was essentially as is described [11] ex-
cept that pGEX-2T was the vector and the primers for polymerase
chain reaction (PCR) ampli¢cation were (i) 5P-GAGAATTCCTAT-
GAAGCATCAGG-3P (underlined nucleotides, EcoRI recognition
site) and (ii) 5P-GCGGCAATCTGGATCAGCTCC-3P. To obtain a
His-tagged TyrRZ, PCR ampli¢ed tyrZ derived from plasmid pGT9
was cloned in the EcoRI site of a modi¢ed version of plasmid pET15b
(Novagen) obtaining plasmid pETYRZ. All cloning procedures were
con¢rmed by DNA sequencing.
2.3. Mutagenesis of tyrZ
PCR was used for the generation of mutations in tyrZ according to
the method described by Higuchi et al. [15]. Mutations were con-
¢rmed by DNA sequencing. Mutated tyrZ was cloned back into
pGT9.
2.4. Complementation of the E. coli HB2109 tyrSts strain
Complementation of the ts mutation in E. coli HB2109 tyrSts with
pGT9 and mutated derivatives was carried out as described [9].
2.5. Overexpression and puri¢cation of TyrRZ
E. coli JM105, transformed by electroporation with pGT9 or mu-
tagenized tyrZ were cultured at 25‡C in Luria broth (LB) with 100 Wg/
ml ampicillin and subjected to induction of expression and puri¢ca-
tion of the protein product essentially as described [16] except that the
lysis bu¡er contained 50 mM Tris pH 8.0, 2 mM EDTA, 0.1% v/v
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Triton X-100, 20 mM 2-mercaptoethanol, 100 Wg/ml lysozyme, 1 mM
phenylmethylsulfonyl £uoride and the fusion protein was eluted with
20 mM glutathione and stored at 320‡C in 45% glycerol in the elution
bu¡er. The fusion protein was, in some cases, subjected to digestion
with thrombin in the elution bu¡er plus 2.5 mM CaCl2 for 1 h at
25‡C or 4‡C overnight. To express the His-tagged TyrRZ, pETYRZ
was electroporated in E. coli BL21(DE3). Cells were cultured at 37‡C
and TyrRZ was induced as described above. Under these conditions
the overexpressed protein was in inclusion bodies that were solubilized
by treatment with guanidine hydrochloride [17]. The soluble protein
was concentrated by ultra¢ltration on Centricon ¢lters.
2.6. In vitro enzymatic activity of TyrRZ
All enzymatic analyses were performed with a⁄nity chromatogra-
phy-puri¢ed GST^TyrRZ fusion product or derivatives. (A) Amino-
acylation of tRNA was carried out in a reaction bu¡er containing
50 mM Tris^HCl pH 8.0, 10 mM MgCl2, 5 mM ATP, 5 mM dithio-
threitol, 100 WM [3H]Tyr (speci¢c activity: 100 mCi/mmol) and
8.0 mg/ml of total E. coli tRNA or variable concentrations of tyro-
sine, ATP or E. coli tRNATyr (Sigma), essentially as is described [18].
(B) The amino acid activation assay was carried out by the [32P]PPi
(NEN) (1^2 cpm/pmol) exchange assay as described [19]. Kinetic anal-
ysis was carried out with variable concentrations of ATP or tyrosine.
The radioactivity was counted in a scintillation counter. (C) The ac-
tive site titration assay was carried out essentially as described [20].
The enzyme (TyrRZ or mutant) was incubated in the proper bu¡er
containing 2 mM ATP, 4 U/ml of inorganic pyrophosphatase and
5 WM [14C]Tyr (497.7 mCi/mmol). The radioactive complex retained
on the nitrocellulose ¢lter (Schleicher and Schuell BA 85) was counted
as previously described. (D) The stability of the Tyr-AMP:TyrRZ
complex was determined as follows. Preparation of the Tyr-AMP
bound to the enzyme was carried out as in the active site titration
reaction but at 4‡C. Known amounts of the ternary complex were
retained on nitrocellulose ¢lters and incubated at room temperature
(21 þ 1‡C) in 700 Wl of a reaction bu¡er containing 10 mM Bis^Tris
propane pH 6.3, 150 mM NaCl and 10 mM MgCl2. At di¡erent
times, a 100 Wl aliquot was spotted on ¢lter paper (3MM Whatman)
and dried to measure the total radioactivity released or on a new
nitrocellulose ¢lter to measure the released ternary complex (this ¢lter
was washed as in the active site titration analysis). The radioactivity
bound to ¢lters was counted in a scintillation counter. The chemical
identity of the free radioactive compound was tested by thin layer
chromatography (TLC) on silica gel (Merck) in a solvent containing
n-propanol:water (70:30). [14C]Tyr was used as marker. The radio-
activity on the plate was processed in a phosphorimager (Bio-Rad).
3. Results
3.1. Functional equivalence of TyrRS and TyrRZ
Based on the divergence in primary structure between
TyrRS and TyrRZ, an important consequence of the multiple
alignment between TyrRS and TyrRZ is that it makes possi-
ble a rational identi¢cation of conserved residues that might
be important for the enzyme function. To develop a system
amenable to further biochemical and molecular genetic anal-
ysis of TyrRZ, we constructed plasmid pGT9 carrying the
coding region of tyrZ as a gst (encoding glutathione-S-trans-
ferase) fusion expressed under the control of isopropyl L-D-
thiogalactopyranoside. The in vivo functionality of the fusion
protein was tested by complementing E. coli HB2109, harbor-
ing a temperature-sensitive tyrS gene, with pGT9. Growth at
the non-permissive temperature (42‡C) was observed in the
transformant with pGT9 but not with pGEX-2T vector alone
Fig. 1. Amino acid sequence alignment of two regions of bacterial tyrosyl-tRNA synthetases. The alignment was carried out with the Clustal
W program [24]. An asterisk (*) represents identical or nearly identical amino acids in all sequences. The HIGH motif is underlined. Positions
of amino acid mutations in A. ferrooxidans TyrRZ are shown in black background. Aferr, A. ferrooxidans ; Aaeol, A. aeolicus ; Hin£, Haemo-
philus in£uenzae ; Hpylo, Helicobacter pylori ; Bsub (S or Z), B. subtilis ; Synec, Synechocystis sp.; Bstea, B. stearothermophilus ; Bcald, Bacillus
caldotenax; Ecoli, E. coli.
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(Table 1), demonstrating the in vivo activity of the fusion
protein in E. coli.
To test the role of conserved amino acids (Fig. 1) in the
functional equivalence of TyrRS and TyrRZ, we carried out
site-directed mutagenesis of tyrZ, based on the known func-
tion of these residues in B. stearothermophilus TyrRS [2,3,21].
The ability of the mutated tyrZ genes to rescue the tyrSts
mutation of E. coli strain HB2109 was then tested (Table 1).
A mutant in H53 (H53A), which is part of the Class I HIGH
signature sequence, was unable to complement. This replace-
ment also abolishes the activation of tyrosine by TyrRZ in
vitro (data not shown). K395 aligns with K410 in B. stearo-
thermophilus TyrRS and is known to participate in tRNA
binding [21]; the K395N tyrZ gene complements very poorly.
Kinetic analysis revealed that the K395N mutation raises the
KM for E. coli tRNA about 17-fold, without a¡ecting the KM
for ATP or tyrosine (Table 2). Three other mutants of con-
served residues in the carboxy-terminal region of tyrZ did not
complement (see below for the biochemical analysis). These
data suggest that certain structural features in A. ferrooxidans
TyrZ are functionally equivalent to those in TyrRS.
3.2. A. ferrooxidans TyrRZ is a homodimer
A⁄nity chromatography on glutathione^agarose of an E.
coli S-100 extract containing heterologously expressed GST^
TyrRZ yielded a nearly 90% pure protein. In agreement with
the prediction from the deduced amino acid sequence a 71
kDa protein was observed. After digestion of the puri¢ed
fusion protein with thrombin, TyrRZ (MW = 46 kDa) and
GST (MW = 27 kDa) were obtained. The kinetic parameters
in the aminoacylation reaction of thrombin-digested and
GST-fused TyrRZ are indistinguishable (data not shown).
The quaternary structure of His-tagged TyrRZ was tested
by gel ¢ltration on a Superose 12 column. A molecular
mass of 105 kDa was obtained. As the molecular mass of
this protein was 48 kDa as judged by sodium dodecyl sul-
fate^polyacrylamide gel electrophoresis (SDS^PAGE) (data
not shown), we conclude that native His-tagged TyrRZ is a
dimer. Although some residues (e.g. P164) involved in dimer-
ization of TyrRS [22] are not conserved in A. ferrooxidans
TyrRZ, this enzyme is also a dimer.
3.3. Role of conserved amino acids in the carboxy-terminal
region of TyrRZ
A sequence alignment of the carboxy-terminal regions of 10
TyrRZ and TyrRS sequences (Fig. 1) highlighted H306 and
S356 as conserved residues. In order to examine the potential
function of these amino acids the following replacements were
made: H306A or D and S356A. As shown above, none of
these mutant tyrZ genes was able to complement the tyrSts
mutation in E. coli strain HB2109 (Table 1) suggesting that
preservation of these amino acids is crucial for TyrRZ func-
Table 1
Complementation of thermosensitive mutation in E. coli tyrS by
tyrZ derivatives
tyrZ derivative Growth of E. coli HB2109 (42‡C)
pGT9 ++
H53A 3
H306A 3
H306D 3
S356A 3
K395N +/3
pGEX-2T 3
Growth of E. coli HB2109 transformed with plasmids carrying wild-
type or mutant tyrZ at 42‡C. pGT9, wild-type tyrZ ; H53A,
H306A,D, S356A and K395N are the tyrZ mutants; pGEX-2T, vec-
tor alone. ++: full growth was observed after 16 h of incubation.
+/3 : few and small colonies were observed at 16 h of incubation
(full growth observed after 48 h). 3 : no colonies were observed at
16 h of incubation.
Table 2
Kinetic parameters of wild-type and mutant tyrosyl-tRNA synthetases
Enzyme Km ATP (mM) Km tyr (WM) Km tRNAtyr (WM) kcat (s31) kcat/Km (ATP) kcat/Km (tyr)
Aminoacylation :
TyrRZ (A. ferrooxidans) 0.13 26.8 2.54 7.7
H306A ^ ^ 3.96 7.2
S356A ^ ^ 19.9 ^
K395N 0.13 ^ 36.7 ^
TyrRS (B. stearothermophilus)a 2.2 2.0 1.4 1.2
ATP^PPi exchange :
TyrRZ (A. ferrooxidans) 0.07 21 5.29 75.6 0.25
H306A 0.035 24 1.63 46.6 0.068
S356A 0.094 21.6 4.28 45.53 0.198
K395N ^ 12 ^ ^ ^
TyrRS (B. stearothermophilus) 0.9 2.4 7.6 8.4 32
H306D, S356A, K395N = TyrRZ with the corresponding mutations.
aObtained from [19,21].
Fig. 2. Stability of the Tyr-AMP intermediate. Release of radioac-
tivity from Tyr-AMP after binding of the Tyr-AMP:TyrRZ complex
to nitrocellulose ¢lters. P, wild-type TyrRZ; 8, H306A mutant
TyrRZ.
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tion. In vitro aminoacylation showed that the S356A protein
has a seven-fold increase in the KM for tRNA (Table 2); no
e¡ect in other kinetic parameters was observed. This strongly
suggests the involvement of S356 in tRNA binding.
Sequence comparison of TyrRS and TyrRZ revealed that
H306 in A. ferrooxidans TyrRZ is located at the junction of
the catalytic and tRNA binding domains. Kinetic analysis of
H306A TyrRZ showed that the KM for neither tyrosine nor
ATP was signi¢cantly altered by the mutation. A three-fold
decrease in the kcat for amino acid activation was observed
(Table 2). The mutation does not appear to a¡ect enzyme
stability or mobility on native PAGE (data not shown) sug-
gesting that the mutant protein does not have a signi¢cantly
altered tertiary structure. An explanation of the decreased
activity of the H306A TyrRZ mutant might be that the stabil-
ity of the Tyr-AMP:TyrRZ complex is altered. To test this,
[14C]Tyr-AMP bound to the enzyme was immobilized to ni-
trocellulose ¢lters and the release of radioactivity (from the
¢lter to the incubation solution) was determined. A 3^4-fold
increase in the release of radioactivity of the mutant TyrRZ
complex was observed when compared to wild-type (Fig. 2).
The released compound was tyrosine (identi¢ed by TLC).
These data suggest that the conserved H at the junction of
catalytic and tRNA binding domains is involved in the stabil-
ity of the Tyr-AMP:TyrRZ ternary complex.
4. Discussion
Sequence alignments of the two tyrosyl-tRNA synthetase
subfamilies TyrRS and TyrRZ highlighted some conserved
residues. Replacement in TyrRZ of some amino acids con-
served between TyrRZ and TyrRS, whose function was
known from studies of B. stearothermophilus TyrRS, led to
changes in TyrRZ activity consistent with the predictions.
Thus, in spite of the divergence in their primary structures,
conserved amino acids apparently perform the same function
in both TyrRZ and TyrRS. These ¢ndings extend our earlier
observation that A. ferrooxidans TyrRZ can functionally re-
place E. coli TyrRS in vivo [9].
Early duplication of the tyrS gene and faster evolution of
one copy due to di¡erent functional constrains has been in-
voked as the reason for the presence of both tyrS and tyrZ
genes in B. subtilis [10]. The availability of a signi¢cant num-
ber of bacterial genome sequences showed that at least 24
species of bacteria possess tyrZ genes. There are nine bacterial
lineages in which tyrZ is found. They include the Aqui¢cales,
green sulfur bacteria, Cyanobacteria, low G+C Gram-positive
bacteria, L-Proteobacteria, Q-Proteobacteria, O-Proteobacteria,
Thermotogales and the Thermus/Deinococcus family. Deep-
rooted organisms like Thermotoga maritima and Aquifex aeo-
licus contain tyrZ as the only gene encoding tyrosyl-tRNA
synthetase. Others (e.g. Clostridium acetobutylicum, Pseudo-
monas aeruginosa, Vibrio cholerae and B. subtilis contain one
copy of each tyrS and tyrZ). Thus the origin of the two di¡er-
ent tyrosyl-tRNA synthetases in the bacterial domain is still
an open question. In light of the currently prevailing view that
contemporary aminoacyl-tRNA synthetases are composed of
functional domains that have been acquired during evolution
to enhance substrate speci¢city [23], a more detailed analysis
of the tRNATyr :TyrRZ complex will be needed to shed more
light on the possible evolutionary divergence of the protein^
RNA interaction in the TyrRS and TyrRZ subfamilies.
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